PYRIDAZINONE COMPOUNDS WHICH MODULATE MUTANT PROTEINS FOR TREATING RESPIRATORY DISEASES

FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS

BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOF

SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS

PYRIDAZINONES AND METHODS OF USE THEREOF

ARYL OR HETEROARYL DERIVATIVE

SUBSTITUTED 5,6-DIPHENYL-3(2H)-PYRIDAZINONES FOR USE AS FUNGICIDES

NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

SUBSTITUTED 1,6-DIHYDROPYRIDINONES AND 1,2-DIHYDROISOQUINOLINONES AS BET INHIBITORS

6-OXO-1,6-DIHYDROPYRIDAZINE PRODRUG DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

Intermediates for preparing herbicidal pyridazinones

Pyridazinone compounds and their use as DAAO inhibitors

Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors

Pyridazinone compounds and their use as DAAO inhibitors

Biaryl amide compounds as kinase inhibitors

Substituted carbonucleoside derivatives useful as anticancer agents

Propionic acid derivatives and methods of use thereof

Pyridazinone compounds and their use as DAAO inhibitors

N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors

Therapeutic compounds and uses thereof

Substituted carbonucleoside derivatives useful as anticancer agents

Biaryl amide compounds as kinase inhibitors

Prodrugs of HIV reverse transcriptase inhibitors

NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF

Cyclohexyl sulfone RORγ modulators

Heterocyclic compounds as bromodomain inhibitors

N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors

Biaryl amide compounds as kinase inhibitors

Pyridazinones as DAAO enzyme inhibitors

Cannabinoid-2 agonists

S1P and/or ATX modulating agents

Pyridazinone compounds and their use as DAAO inhibitors

Phosphodiesterase 4 inhibitor capable of avoiding vomiting

BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Pyridazinone compound and herbicide and noxious arthropod controlling agent comprising it

Multifunctional radical quenchers and their uses

DERIVATIVES OF OXADIAZOLE AND PYRIDAZINE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

Ethynyl derivatives

Cannabinoid-2 agonists

NOVEL COMPOUNDS

Compositions useful as inhibitors of voltage-gated sodium channels

Derivatives of 2H pyridazin-3-ones, their preparation and their use as SCD-1 inhibitors

CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

UREA COMPOUND OR SALT THEREOF

Substituted 6-(1-piperazinyl)-pyridazines as 5-HTreceptor antagonists

Pyridazinone compounds and P2X7 receptor inhibitors

Amine derivative having NPY Y5 receptor antagonistic activity

Compositions useful as inhibitors of voltage-gated sodium channels

Kinase inhibitor compounds

Amine derivative having NPY Y5 receptor antagonistic activity

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Bisaryl-sulfonamides

Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS

Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Heteroaromatic glucokinase activators

Immunosuppressant compounds and compositions

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Dipiperazinyl ketones and related analogues

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

Pyridazine derivatives and their use as therapeutic agents

Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)

Bisaryl-sulfonamides

Pyridazin-3(2)-one derivatives as PDE4 inhibitors

Compositions useful as inhibitors of voltage-gated sodium channels

Pyridazine derivatives and their use as therapeutic agents

Substituted 2-phenyl-3(2h)-pyridazinones

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

Heteroaromatic glucokinase activators

Substituted pyridazinones

3-Heterocyclyl substituted benzoic acid derivatives

Compositions useful as inhibitors of voltage-gated sodium channels

Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same

Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds

Substituted pyridazinones